Comparative characteristics of structural and functional echocardiographic parameters in patients with familial hypertrophic cardiomyopathy with MYBPC3 and MYH7 gene variants

Aim. To compare echocardiographic parameters in patients with familial hypertrophic cardiomyopathy and confirmed variants in the MYH7 and MYBPC3 genes.

Material and methods. This study included a comprehensive assessment of echocardiographic parameters in 48 patients with hypertrophic cardiomyopathy, including 14 men and 34 women, aged 18-77 years. Subjects were divided into two groups based on confirmed variants in the MYH7 and MYBPC3 genes.

Results. Patients with a MYBPC3 gene variant had significantly larger right atrial size and left ventricular (LV) posterior wall thickness (p=0,42, p=0,002), while LV systolic function, assessed using the additional speckle tracking echocardiography, was significantly lower compared to patients with a variant in the MYH7 gene (p=0,021).

Conclusion. Patients with a variant in the MYBPC3 gene showed significant changes in structural and functional echocardiography parameters, indicating a less favorable prognosis for this group of patients.

1. Bokeria LA, Shlyakhto EV, Gabrusenko SA, et al. 2025 Clinical practice guidelines for Hypertrophic cardiomyopathy. Russian Journal of Cardiology. 2025;30(5):6387. (In Russ.) doi:10.15829/1560-4071-2025-6387.

2. Massera D, Sherrid MV, Maron MS, et al. How common is hyper­trophic cardiomyopathy… really?: Disease prevalence revisited 27 years after CARDIA. Int J Cardiol. 2023;382:64-7. doi:10.1016/j.ijcard.2023.04.005.

3. Dementyeva EV, Vyatkin YV, Kretov EI, et al. Genetic analysis of patients with hypertrophic cardiomyopathy. Genes & Cells. 2020;15(3):68-73. (In Russ.) doi:10.23868/202011011.

4. Ignatenko GA, Taradin GG, Rakitskaya IV. Methods of visualization in the diagnosis of hypertrophic cardiomyopathy. Current issues in medicine. 2023;46(4):351-67. (In Russ.) doi:10.52575/2687-0940-2023-46-4-351-367.

5. Keramida K, Lazaros G, Nihoyannopoulos P. Right ventricular invol­vement in hypertrophic cardiomyopathy: Patterns and impli­cations. Hellenic J Cardiol. 2020;61(1):3-8. doi:10.1016/j.hjc.2018.11.009.

6. Marstrand P, Han L, Day SM, et al. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction Insights From the SHaRe Registry. Circulation. 2020;141(17):1371-83. doi:10.1161/circulationaha.119.044366.

7. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardio­vas­cular Imaging. J Am Soc Echocardiogr. 2016;29(4):277-314. doi:10.1016/j.echo.2016.01.011.

8. Nikiforov VS, Nikishchenkova IV. Modern Possibilities of Speckle Tracking Echocardiography in Clinical Practice. Rational Phar­ma­co­therapy in Cardiology 2017;13(2):248-55. (In Russ.) doi:10.20996/1819-6446-2017-13-2-248-255.

9. Nefedova DA, Myasnikov RP, Kulikova OV, et al. MYBPC3-asso­ciated cardiomyopathy: features of the course and prospects for specific therapy. Cardiovascular Therapy and Prevention. 2024;23(12):4257. (In Russ.) doi:10.15829/1728-8800-2024-4257.

10. Höller V, Seebacher H, Zach D, et al. Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-­The Graz Hypertrophic Cardiomyopathy Re­gi­stry. Genes (Basel). 2021;12(10):1469. doi:10.3390/genes12101469.

11. Beltrami M, Fedele E, Fumagalli C, et al. Long-­Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hyper­trophic Cardiomyopathy. Circ Genom Precis Med. 2023; 16(4):363-71. doi:10.1161/CIRCGEN.122.003832.

12. Zhou N, Weng H, Zhao W, et al. Gene-echocardiography: refi­ning genotype-­phenotype correlations in hypertrophic cardio­myopathy. Eur Heart J Cardiovasc Imaging. 2023;25(1):127-35. doi:10.1093/ehjci/jead200.